Omega-3 supplementation in the treatment of children with ADHD

 
 
 

Attention Deficit/ Hyperactivity Disorder (ADHD) is a common child disorder, often treated with stimulant medication (methylphenidate). But lately, the interest in non-pharmacological treatments is increasing, due mainly by the secondary effects of medication. These approaches include dietary supplementation with omega-3 fatty acids.

To evaluate the effects of dietary omega-3 fatty acid supplementation on ADHD symptoms in boys aged 8-14 years with and without ADHD, 44 boys with ADHD and 39 without this disorder (the reference group) were included in a study in which they consumed daily 10 g of margarine enriched with EPA or DHA or placebo (a substance that has no physical effect), for 16 weeks. The outcomes support what we have explained previously: dietary supplementation with omega-3 fatty acids may reduce symptoms of ADHD. Supplementation with omega-3 improved symptoms of inattention both in boys with and without ADHD. Furthermore, there was an effect of treatment on parent-rated symptoms of ADHD, regardless of diagnosis: EPA/DHA supplementation improved parent-rated attention in both children with and without ADHD.

Moreover, this study supports the idea that omega-3 supplementation may be an effective augmentation for pharmacological treatments of ADHD: the majority of children with ADHD received the omega-3 supplements in addition to their regular medication. Even taking into account changes in medication, the behavioral improvement persisted. This supports recent reports that showed that children receiving a combination of methylphenidate and omega-3 needed lower doses of methylphenidate, compared to children only receiving methylphenidate, to achieve the same benefits.

Omega-3 supplementation may be useful as an augmentation to standard pharmacological treatment in children with ADHD.

 

Bibliography:

Bos DJ, Oranje B, Veerhoek ES et al. Reduced symptoms of inattention after Dietary Omega-3 Fatty Acid Supplementation in boys with and without Attention Deficit/Hyperactivity Disorder. Neuropsychopharmacology. 2015 Mar 19. doi: 10.1038/npp.2015.73. [Epub ahead of print]

 
 

DHA and prevention of cognitive problems

During gestation, DHA accumulates in brain tissue (especially during the third trimester). After birth and during childhood, DHA levels continue to increase in the areas associated[...]

 
 

Restoring omega-6/omega-3 balance in ADHD

Attention Deficit Hyperactivity Disorder (ADHD) is a common neurological development disorder characterized by symptoms of inattention, hyperactivity, and impulsivity, among whose [...]